Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Meningitis
Scientific panel finds long-lasting vaccine for Africa promising
March 31st, 2003
The Meningitis Vaccine Project (MVP), a partnership between the World Health Organization (WHO) and the Seattle-based Program for Appropriate Technology in Health (PATH), has announced a major milestone forward in the fight against the deadly meningitis A epidemics that have plagued sub-Saharan Africa for more than 100 years. A panel of scientific experts has determined that MVP's candidate meningitis A conjugate vaccine has a strong chance of providing long-lasting immunity against meningitis to people in Africa. The scientists, assembled by MVP (www.meningvax.org) and the U.K.-based National Institute for Biological Standards and Control (NIBSC),...
Source: Pain & Central Nervous System Week (2003-03-31)
|
